Table 2.
Adverse events (AEs) and laboratory abnormalities of overall patients
| Side effects | Overall patients (99) |
|---|---|
| Any adverse event during treatment, n | 76 |
| Adverse event leading to discontinuation, n | 0 |
| Serious adverse events, n | 3 |
| Adverse events ≥ 10% of patients, n | |
| Fatigue | 48 |
| Headache | 39 |
| Nausea | 36 |
| Dyspnea | 27 |
| Influenza-like illness (fever, myalgia, rigors) | 26 |
| Insomnia | 22 |
| Rash (any type) | 17 |
| Irritability | 23 |
| Diarrhea | 11 |
| Laboratory abnormality, n (%) | |
| Anemia | 40 |
| Thrombocytopenia | 36 |
| Leukopenia | 32 |
ALT – alanine aminotransferase, AST – aspartate aminotransferase